Aluminum Phosphate Clinical Trials

Paid Clinical Trials > Browse Categories > Medications / Interventions > Aa > Aluminum Phosphate

Aluminum Phosphate

All Categories Medications / Interventions » Aa » Aluminum Phosphate

Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study

Condition: SARS
Interventions: Drug: Aluminum hydroxide adjuvant (Alhydrogel®); Other: Phosphate buffered saline Placebo; Biological: Recombinant S protein SARS vaccine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified April 2012

Main Menu

Clinical Trial Categories

Clinical Trial Locations

Sponsors/Recruiting

Join Clinical Trials

Patient Accounts| Sponsor Accounts | Paid Cliical Trials | Find Patients | Clinical Trail Jobs | Articles |Privacy Policy | Email Policy | Terms of Use | HIPPA |Contact Us | Sitemap
All information is pulled by the U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. Note: PaidClinicalTrials.org, paidclinicaltrials.org (Aunica Media llc) are resources that provide individuals with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free